Lowest Price Guaranteed From USD 4,799
The continuous manufacturing systems market is estimated to be worth $445 million in 2021 and is expected to grow at compounded annual growth rate (CAGR) of 12% during the forecast period. Pharmaceutical manufacturing processes are complex, time consuming, as well as cost intensive. In fact, it is estimated that production inefficiencies and product recalls (owing to manufacturing errors) are responsible for annual losses amounting to around USD 50 billion. Given the ever-increasing demand for pharmacological interventions, and the introduction of new and sophisticated therapeutic modalities, drug substance manufacturers are gradually opting for more advanced manufacturing solutions, such as continuous flow reactor. When compared to the conventional batch manufacturing process, the continuous mode of production has been demonstrated to allow significant cost savings (around 40% to 50% of expenditure when using traditional equipment). According to the USFDA, using the continuous approach, it is even possible for industry stakeholders to significantly abbreviate production time; for instance, a drug that previously required a month to manufacture, can now be produced in a single day. Continuous processing also enables manufacturers to circumvent concerns related to equipment downtime, and use the entire capacity of production lines, while simultaneously testing the quality of products / production intermediates. Moreover, a continuous manufacturing facility requires 70% less area than a plant that is designed for running batch processes; this enables additional savings, in terms of facility operation costs. Further, continuous manufacturing processes can be automated, and the affiliated equipment usually includes a variety of advanced features that offer real-time visibility on various important parameters. Overall, the adoption of continuous flow reactor technologies is believed to possess the potential to notably improve productivity, while minimizing batch-to-batch variability. So far, the US FDA has approved four therapies that were produced using the continuous manufacturing approach. In addition, there are over 20 product candidates that are currently being manufactured via the same approach.
Considering the various advantages of continuous manufacturing, pharmaceutical developers are gradually becoming more receptive to adopting such solutions. As a matter of fact, the recent surge in demand for pharmaceuticals amidst the COVID-19 pandemic, has served to create a strong case for pharmaceutical companies to develop the means to produce drugs faster. Moreover, the Centre for Drug Evaluation and Research (CDER) and US Biomedical Advanced Research and Development Authority (BRADA), are currently working closely to promote the use of continuous manufacturing for the production of therapeutics for medical emergencies. As a result, several industry stakeholders that are involved in drug development and production, have already made significant investments towards acquiring continuous manufacturing capabilities and the associated expertise. On the other hand, there are several companies that are now offering continuous manufacturing equipment that contain process analytical technologies (PAT) and advanced sensors. Further, many innovators claim to be engaged in improving the continuous manufacturing process, developing advanced variants of currently available processing systems, and optimizing on the cost of such solutions. The aforementioned developments are anticipated to result in an increase in adoption of continuous processing technologies, during the forecast period.
Examples of key companies engaged in continuous manufacturing system market (which have also been profiled in this market report; the complete list of companies is available in the full report) include Corning, Glatt, IKA, Kilburn Engineering, Thermo Fisher Scientific, Eppendorf, Merck Millipore, Pall, Sartorius and TA Instruments. This market report includes an easily searchable excel database of all the companies providing continuous manufacturing systems including perfusion bioreactors, continuous mixers, blenders, grinders and others, worldwide.
Several recent developments have taken place in the field of continuous manufacturing systems market. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.
The “Continuous Manufacturing Systems Market by Type of Molecule (Small Molecules and Biologics), Type of Equipment (Mixers, Granulators, Continuous Bioreactor / Reactors and Others), Stage of Manufacturing (Upstream and Downstream Process), Scale of Operation (Preclinical / Clinical and Commercial) and Geography (North America, Europe and Asia Pacific), 2021-2030” market report offers an elaborate study of the current market landscape, market size, market share, market growth, market forecast, market outlook and future opportunities of the continuous manufacturing systems market. The market research report features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in continuous manufacturing systems market. In addition to other elements, the market research report includes:
The key objective of continuous manufacturing systems market report is to provide a detailed market analysis in order to estimate the existing market size, market value, statistics and future opportunity for continuous manufacturing systems market during the forecast period. We have provided an informed estimate to the likely evolution of the market in the short to mid-term and long term, for the forecast period of 2021-2030. Our year-wise projections of the current and future opportunity have further been segmented based on [A] type of molecule (small molecule and biologic), [B] type of equipment (mixers, granulators, continuous bioreactor / reactors and others), [C] scale of operation (preclinical / clinical and commercial), stage of manufacturing (upstream and downstream process) and [D] geography (North America, Europe and Asia Pacific).
The opinions and insights presented in this market research report were influenced by discussions conducted with several stakeholders in continuous manufacturing systems market. The market report features detailed transcripts of interviews held with the following individuals:
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this market report are in USD, unless otherwise specified.